These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 19886148)

  • 21. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
    Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
    Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.
    Ollendorf DA; Lidsky L
    Am J Ther; 2006; 13(6):502-6. PubMed ID: 17122530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease.
    Krane MK; Allaix ME; Zoccali M; Umanskiy K; Rubin MA; Villa A; Hurst RD; Fichera A
    Dis Colon Rectum; 2013 Apr; 56(4):449-57. PubMed ID: 23478612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.
    Ananthakrishnan AN; McGinley EL; Binion DG
    Gut; 2008 Feb; 57(2):205-10. PubMed ID: 17905821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of persistence with infliximab on hospitalizations in ulcerative colitis.
    Carter CT; Leher H; Smith P; Smith DB; Waters HC
    Am J Manag Care; 2011 Jun; 17(6):385-92. PubMed ID: 21756009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverticulitis in California from 1995 to 2006: increased rates of treatment for younger patients.
    Etzioni DA; Cannom RR; Ault GT; Beart RW; Kaiser AM
    Am Surg; 2009 Oct; 75(10):981-5. PubMed ID: 19886149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical and nonsurgical hospitalization rates and charges for patients with ulcerative colitis in Italy: a 10-year cohort study.
    Kohn A; Fano V; Monterubbianesi R; Davoli M; Marrollo M; Stasi E; Perucci C; Prantera C
    Dig Liver Dis; 2012 May; 44(5):369-74. PubMed ID: 22197692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
    Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
    Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
    Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.
    Moore SE; McGrail KM; Peterson S; Raval MJ; Karimuddin AA; Phang PT; Bressler B; Brown CJ
    Dis Colon Rectum; 2014 Jan; 57(1):83-90. PubMed ID: 24316950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
    Rutgeerts P; Vermeire S; Van Assche G
    Gut; 2007 Apr; 56(4):453-5. PubMed ID: 17369375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infliximab--practical guidelines for the treatment of Crohn's disease].
    Bauerfeind P; Beglinger C; Beltinger J; Braegger C; Eigenmann F; Fried M; Guyot J; Hürlimann R; Michetti P; Seibold F; Straumann A
    Rev Med Suisse; 2006 Jul; 2(74):1807-15. PubMed ID: 16927560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with biologic therapies and the risk of cancer in patients with IBD.
    Biancone L; Calabrese E; Petruzziello C; Pallone F
    Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):78-91. PubMed ID: 17268543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
    Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
    Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease.
    Thakkar K; Lucia CJ; Ferry GD; McDuffie A; Watson K; Tsou M; Gilger MA
    Am J Gastroenterol; 2009 Mar; 104(3):722-7. PubMed ID: 19209163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.